Europe Closed System Transfer Devices Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The Europe closed system transfer devices
market was estimated to be worth USD 994 million in 2023 and is
expected to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to
2034, or USD 3.5 billion. Closed System Transfer Devices improve patient and
healthcare worker safety and wellbeing. The market is increasing and
sustainable since it is in line with the healthcare industry.
The main advantages of CSTDs are that they can reduce the
danger of occupational exposure by acting as a strong barrier between
healthcare personnel and hazardous medications. CSTDs, which protect against
inhalation and direct contact with hazardous compounds, are essential for
maintaining the health and safety of medical professionals who handle and
administer drugs. Drug spillage can happen during the transfer process, and
CSTDs help to reduce that risk. Healthcare facilities must abide by these laws
to maintain a safe working environment and protect the health and safety of
both staff and patients. The usage of CSTDs assures compliance with the strict
safety regulations and recommendations issued by organizations such as OSHA and
NIOSH.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/europe-closed-system-transfer-devices-market
GROWTH DRIVERS
The need for Closed System Transfer Devices (CSTDs) is
being driven by the increased incidence of cancer worldwide, especially in
Europe. Chemotherapy is still a major cancer treatment, and it is critical to
handle dangerous medications safely using CSTDs in order to protect patients
and healthcare personnel. The World Health Organization (WHO) reports that
there are more than 3.7 million new instances of cancer and 1.9 million
cancer-related deaths in Europe annually. In Europe, cancer ranks as the second
most common cause of death and sickness.
Healthcare professionals run the risk of coming into
contact with cytotoxic medications, which can have a negative impact on their
health. By offering a strong shield against exposure, CSTDs allay these safety
worries and propel industry expansion. The CSTD industry is
expanding as a result of increased healthcare spending in Europe, including
funding from InvestEU and High-Tech Grunderfonds (HTGF).
Healthcare facilities spend money on modern medical
devices—such as CSTDs—in order to meet regulatory criteria and improve safety
standards. The market is expanding as a result of technological developments in
CSTDs, including better sealing mechanisms, creative design elements, and
increased compatibility with current drug delivery systems.
MARKET
SEGMENTATION:
· By
Type – membrane-to-membrane systems, needless systems
· By
Closing Mechanism Type – Luer Lock Systems, push-to-turn system,
click-to-lock system, color-to-color alignment system
· By
Component Type – vial access components, male Luers, bag spikes,
female components and others
· By
Technology – diaphragm-based devices, compartmentalized devices and
air cleaning/filtration devices
Global Key
Players:
· B.
Braun Holding GmbH and Co. KG
· Caragen
Ltd.
For
More Information about this Report @ https://www.xresearch.biz/shop/europe-closed-system-transfer-devices-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment